Targeting N-Cadherin through Fibroblast Growth Factor Receptor-4: Distinct Pathogenetic and Therapeutic Implications

Shereen Ezzat(Ontario Institute for Cancer Research), L. Sylvia(Mount Sinai Hospital)
Molecular Endocrinology
July 21, 2006
Cited by 53


Related Papers